CIK Treatment for HCC Patient Underwent Radical Resection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
This is a randomized controlled study. About 200 patients with hepatocellular carcinoma who underwent radical resection will be included. The patients will be randomized to group A (receive CIK treatment) or group B (just regularly follow up) without any anti-cancer treatment after resection of HCC, and the randomize ratio will be 1:1.
Epistemonikos ID: 056349ec2084fddc4e97728674c87c4cea66e541
First added on: May 11, 2024